SRRK Competitors & Alternatives
Compare Scholar Rock Holding Corp with similar stocks in the same industry
Biotechnology
SRRK
Main Stock$49.35
Tradestie Score
60
Market Cap
$3.33B
Revenue Growth
-1.0%
Analyst Upside
+19.6%
Top Competitors
228 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
MRUS
Merus N.V. Common Shares
|
$90.00
|
$7.14B | - | 55 | Compare |
|
CYTK
Cytokinetics Inc.
|
$75.85
|
$6.68B | - | 62 | Compare |
|
RYTM
Rhythm Pharmaceuticals, Inc. Common Stock
|
$90.52
|
$6.64B | - | 58 | Compare |
|
ABVX
Abivax SA American Depositary Shares
|
$114.53
|
$6.38B | - | 46 | Compare |
|
LEGN
Legend Biotech Corporation American Depositary Shares
|
$27.55
|
$6.03B | - | 57 | Compare |
|
CRSP
CRISPR Therapeutics AG
|
$48.41
|
$6.02B | - | 50 | Compare |
|
NUVL
Nuvalent, Inc. Class A Common Stock
|
$102.30
|
$5.95B | - | 51 | Compare |
|
AXSM
Axsome Therapeutics, Inc
|
$227.72
|
$5.92B | - | 61 | Compare |
|
TGTX
TG Therapeutics, Inc.
|
$39.50
|
$5.80B | 14.9 | 60 | Compare |
|
KRYS
Krystal Biotech, Inc. Common Stock
|
$306.29
|
$5.20B | 41.3 | 64 | Compare |
More SRRK Analysis
Data updated: May 18, 2026 | Industry: Biotechnology (SIC 2836)
228 stocks in this industry